B cells imprint adoptively transferred CD8+ T cells with enhanced tumor immunity
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
B cells imprint adoptively transferred CD8+ T cells with enhanced tumor immunity
Authors
Keywords
-
Journal
Journal for ImmunoTherapy of Cancer
Volume 10, Issue 1, Pages e003078
Publisher
BMJ
Online
2022-01-12
DOI
10.1136/jitc-2021-003078
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Tilsotolimod with ipilimumab drives tumor responses in anti-PD-1 refractory melanoma
- (2021) Cara Haymaker et al. Cancer Discovery
- B cells are associated with survival and immunotherapy response in sarcoma
- (2020) Florent Petitprez et al. NATURE
- Tertiary lymphoid structures improve immunotherapy and survival in melanoma
- (2020) Rita Cabrita et al. NATURE
- B cells and tertiary lymphoid structures promote immunotherapy response
- (2020) Beth A. Helmink et al. NATURE
- Stem-like CD8 T cells mediate response of adoptive cell immunotherapy against human cancer
- (2020) Sri Krishna et al. SCIENCE
- Targeted APC Activation in Cancer Immunotherapy to Enhance the Abscopal Effect
- (2019) Nathan Suek et al. Frontiers in Immunology
- Targeting Adenosine in Cancer Immunotherapy to Enhance T-Cell Function
- (2019) Selena Vigano et al. Frontiers in Immunology
- In Situ Vaccination with a TLR9 Agonist and Local Low-Dose Radiation Induces Systemic Responses in Untreated Indolent Lymphoma
- (2018) Matthew J. Frank et al. Cancer Discovery
- SD-101 in Combination with Pembrolizumab in Advanced Melanoma: Results of a Phase Ib, Multicenter Study
- (2018) Antoni Ribas et al. Cancer Discovery
- The PRIDE database and related tools and resources in 2019: improving support for quantification data
- (2018) Yasset Perez-Riverol et al. NUCLEIC ACIDS RESEARCH
- Toll-like receptor stimulation in cancer: A pro- and anti-tumor double-edged sword
- (2017) Marion Dajon et al. IMMUNOBIOLOGY
- Antigen-Presenting Intratumoral B Cells Affect CD4 + TIL Phenotypes in Non–Small Cell Lung Cancer Patients
- (2017) Tullia C. Bruno et al. Cancer Immunology Research
- PI3Kδ Inhibition Enhances the Antitumor Fitness of Adoptively Transferred CD8+ T Cells
- (2017) Jacob S. Bowers et al. Frontiers in Immunology
- Defining CD8+ T cells that provide the proliferative burst after PD-1 therapy
- (2016) Se Jin Im et al. NATURE
- The Perseus computational platform for comprehensive analysis of (prote)omics data
- (2016) Stefka Tyanova et al. NATURE METHODS
- The MaxQuant computational platform for mass spectrometry-based shotgun proteomics
- (2016) Stefka Tyanova et al. Nature Protocols
- Expression of CD39 on Activated T Cells Impairs their Survival in Older Individuals
- (2016) Fengqin Fang et al. Cell Reports
- Toll-like receptor agonist therapy can profoundly augment the antitumor activity of adoptively transferred CD8+ T cells without host preconditioning
- (2016) Michelle H. Nelson et al. Journal for ImmunoTherapy of Cancer
- The Inducible Costimulator Augments Tc17 Cell Responses to Self and Tumor Tissue
- (2015) Michelle H. Nelson et al. JOURNAL OF IMMUNOLOGY
- Adoptive cell transfer as personalized immunotherapy for human cancer
- (2015) S. A. Rosenberg et al. SCIENCE
- IL-2Rα mediates temporal regulation of IL-2 signaling and enhances immunotherapy
- (2015) Ee W. Su et al. Science Translational Medicine
- CD39 Expression Identifies Terminally Exhausted CD8+ T Cells
- (2015) Prakash K. Gupta et al. PLoS Pathogens
- Phase 2, open-label, 1:1 randomized controlled trial exploring the efficacy of EMD 1201081 in combination with cetuximab in second-line cetuximab-naïve patients with recurrent or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN)
- (2014) A. Ruzsa et al. INVESTIGATIONAL NEW DRUGS
- Accurate Proteome-wide Label-free Quantification by Delayed Normalization and Maximal Peptide Ratio Extraction, Termed MaxLFQ
- (2014) Jürgen Cox et al. MOLECULAR & CELLULAR PROTEOMICS
- CD8 memory T cells have a bioenergetic advantage that underlies their rapid recall ability
- (2013) G. J. W. van der Windt et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Ex Vivo Interleukin-12-Priming During CD8+ T Cell Activation Dramatically Improves Adoptive T Cell Transfer Antitumor Efficacy in a Lymphodepleted Host
- (2012) Mark P. Rubinstein et al. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS
- Immune Tolerance to Tumor Antigens Occurs in a Specialized Environment of the Spleen
- (2012) Stefano Ugel et al. Cell Reports
- In situ vaccination against mycosis fungoides by intratumoral injection of a TLR9 agonist combined with radiation: a phase 1/2 study
- (2011) Y. H. Kim et al. BLOOD
- Adoptive immunotherapy combined with intratumoral TLR agonist delivery eradicates established melanoma in mice
- (2011) Sally M. Amos et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- The ICOS/ICOSL Pathway Is Required for Optimal Antitumor Responses Mediated by Anti-CTLA-4 Therapy
- (2011) T. Fu et al. CANCER RESEARCH
- Mitochondrial Respiratory Capacity Is a Critical Regulator of CD8+ T Cell Memory Development
- (2011) Gerritje J.W. van der Windt et al. IMMUNITY
- The pharmacokinetics of Toll-like receptor agonists and the impact on the immune system
- (2011) Abbi L Engel et al. Expert Review of Clinical Pharmacology
- Down-Regulation of TLR9 Expression Affects the Maturation and Function of Murine Bone Marrow-Derived Dendritic Cells Induced by CpG
- (2010) Ling Ma et al. Cellular & Molecular Immunology
- In Situ Vaccination With a TLR9 Agonist Induces Systemic Lymphoma Regression: A Phase I/II Study
- (2010) Joshua D. Brody et al. JOURNAL OF CLINICAL ONCOLOGY
- The Inducible Costimulator (ICOS) Is Critical for the Development of Human TH17 Cells
- (2010) C. M. Paulos et al. Science Translational Medicine
- Randomized phase 2/3 trial of CpG oligodeoxynucleotide PF-3512676 alone or with dacarbazine for patients with unresectable stage III and IV melanoma
- (2009) Jeffrey S. Weber et al. CANCER
- Tumor-reactive CD8+T-cell responses after vaccination with NY-ESO-1 peptide, CpG 7909 and Montanide® ISA-51: Association with survival
- (2009) Julia Karbach et al. INTERNATIONAL JOURNAL OF CANCER
- Enhancing CD8 T-cell memory by modulating fatty acid metabolism
- (2009) Erika L. Pearce et al. NATURE
- MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification
- (2008) Jürgen Cox et al. NATURE BIOTECHNOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now